HEP-25 25000IU INJECTION
Unfractionated Heparins Systemic(25000 iu)
Gland Pharma Ltd
It is available as a solution for injection to be administered by a healthcare provider into the vein.
Store at a temperature not exceeding 30°C.
Hypersensitivity to heparin Haemophilia and other haemorrhagic disorders Thrombocytopenia Peptic ulcer Recent cerebral haemorrhage Severe hypertension Severe liver or renal disease After major trauma or recent surgery (especially to eye or nervous system) Threatened abortion Piles Bacterial endocarditis Large malignancies Tuberculosis Lumbar puncture Chronic alcoholics Acetylsalicylic acid and other antiplatelet drugs
Graves' disease : Graves' disease (or Basedow-Graves disease) is an autoimmune disease. It most commonly affects the thyroid, frequently causing it to enlarge to twice its size or more (goiter), become overactive, with related hyperthyroid symptoms such as increased heartbeat, muscle weakness, disturbed sleep, and irritability. Treatment of Graves' disease includes antithyroid drugs which reduce the production of thyroid hormone; radioiodine (radioactive iodine I-131); and thyroidectomy (surgical excision of the gland) Hyperthyroidism : Hyperthyroidism is a condition in which an overactive thyroid gland is producing an excessive amount ofthyroid hormones that circulate in the blood. ("Hyper" means "over" in Greek). Thyrotoxicosis is a toxic condition that is caused by an excess of thyroid hormones from any cause. Thyrotoxicosis can be caused by an excessive intake of thyroid hormone or by overproduction of thyroid hormones by the thyroid gland. TREATMENT Treatment depends on the cause and the severity of symptoms. Hyperthyroidism is usually treated with one or more of the following: • Antithyroid medications • Radioactive iodine to destroy the thyroid gland and stops the excess production of hormones • Surgery to remove the thyroid Medicines called beta-blockers may be prescribed to treat symptoms such as fast heart rate, sweating, and anxiety until the hyperthyroidism can be controlled.
Cephalosporins which contain the MTT side chain may increase the risk of hemorrhage. Drugs which affect platelet function (eg, aspirin, NSAIDs, dipyridamole, ticlopidine, clopidogrel) may potentiate the risk of hemorrhage. Nitroglycerin (I.V.) may decrease heparin's anticoagulant effect. This interaction has not been validated in some studies, and may only occur at high nitroglycerin dosages. Penicillins (parenteral) may prolong bleeding time via inhibition of platelet aggregation, potentially increasing the risk of hemorrhage. Thrombolytic agents increase the risk of hemorrhage. Warfarin: Risk of bleeding may be increased during concurrent therapy. Heparin is commonly continued during the initiation of warfarin therapy to assure anticoagulation and to protect against possible transient hypercoagulability. Other drugs reported to increase heparin's anticoagulant effect include antihistamines, tetracycline, quinine, nicotine, and cardiac glycosides (digoxin).
Whether you're looking for a doctor for dealing with your own medical condition, click here to find right physician.
It is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant.